Franklin Street Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Franklin Street Advisors’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-13,612	Closed	-$651K	–	167
2016 Q4	$651K	Hold	13,612	–	–	0.11%	112
2016 Q3	$499K	Hold	13,612	–	–	0.09%	129
2016 Q2	$317K	Sell	13,612 -1,600	-11%	-$51.6K	0.06%	153
2016 Q1	$616K	Sell	15,212 -3,400	-18%	-$138K	0.12%	128
2015 Q4	$1.15M	Hold	18,612	–	–	0.23%	108
2015 Q3	$753K	Hold	18,612	–	–	0.15%	125
2015 Q2	$1.07M	Hold	18,612	–	–	0.19%	113
2015 Q1	$1.19M	Sell	18,612 -5,000	-21%	-$339K	0.22%	107
2014 Q4	$1.46M	Hold	23,612	–	–	0.28%	91
2014 Q3	$917K	Hold	23,612	–	–	0.17%	116
2014 Q2	$813K	Hold	23,612	–	–	0.16%	131
2014 Q1	$1.02M	Hold	23,612	–	–	0.2%	111
2013 Q4	$940K	Hold	23,612	–	–	0.19%	119
2013 Q3	$886K	Sell	23,612 -21,500	-48%	-$642K	0.2%	127
2013 Q2	$1.21M	Buy	+45,112	New	+$959K	0.3%	89

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Franklin Street Advisors's IONS Position: Q1 2017 in Review

Franklin Street Advisors sold out of Ionis Pharmaceuticals (IONS) in Q1 2017, closing a stake of 13,612 shares — an estimated $651K sold.

Franklin Street Advisors first reported a position in IONS in Q2 2013 and held it in 15 quarters. The position peaked at $1.46M in Q4 2014. 270 funds tracked by Wall St. Rank hold IONS as of Q1 2017.

Franklin Street Advisors reported no remaining Ionis Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
Franklin Street Advisors sold 13,612 Ionis Pharmaceuticals shares in Q1 2017, an estimated $651K.
Franklin Street Advisors first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 15 quarters.
Franklin Street Advisors's Ionis Pharmaceuticals position peaked at $1.46M in Q4 2014.
270 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2017.

Based on Franklin Street Advisors's 13F filing for Q1 2017, filed 4 Apr 2017.